NEWS
Making it easy for our investors to stay current with our portfolio companies and their industries.
November 30, 2021
Intensity Therapeutics Announces New Clinical Data Presentation for its Lead Asset, INT230-6, in Breast Cancer, at the 2021 San Antonio Breast Cancer Symposium® in December
November 17, 2021
ATLAS ushers smart space comms into future with SBIR
November 12, 2021
Intensity Therapeutics Reports Use of INT230-6 Alone or in Combination with Ipilimumab Shows Evidence of Direct Tumor Necrosis and Promising Overall Survival Results in Adult Subjects with Metastatic Sarcomas at the Connective Tissue Oncology Society (CTOS) 2021 Virtual Annual Meeting
November 11, 2021
Atlas included among Michigan companies as best employers of veterans
November 9, 2021
ATLAS Named To Military Times “Best For Vets”